This announcement is a separate document:
ジーエヌアイグループ：Gyre Therapeuticsによる2024年度第１四半期概要及び事業ハイライトのプレスリリースについて
GNI Group: Gyre Therapeutics' press release on the 2024 1st quarter overview and business highlights
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.